These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 10873032

  • 1. 16q loss of heterozygosity and microsatellite instability in Wilms' tumor.
    Mason JE, Goodfellow PJ, Grundy PE, Skinner MA.
    J Pediatr Surg; 2000 Jun; 35(6):891-6; discussion 896-7. PubMed ID: 10873032
    [Abstract] [Full Text] [Related]

  • 2. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G, Rieske P, Bartkowiak J, Szymik-Kantorowicz S, Daszkiewicz P, Debiec-Rychter M.
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [Abstract] [Full Text] [Related]

  • 3. Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases.
    Safford SD, Goyeau D, Freemerman AJ, Bentley R, Everett ML, Grundy PE, Skinner MA.
    Ann Surg Oncol; 2003 Mar; 10(2):136-43. PubMed ID: 12620908
    [Abstract] [Full Text] [Related]

  • 4. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
    Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC.
    Cancer Res; 1994 May 01; 54(9):2331-3. PubMed ID: 8162576
    [Abstract] [Full Text] [Related]

  • 5. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PR, Macklis R, Tomlinson G, Huff V, Green DM, National Wilms Tumor Study Group.
    J Clin Oncol; 2005 Oct 10; 23(29):7312-21. PubMed ID: 16129848
    [Abstract] [Full Text] [Related]

  • 6. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
    Lin YW, Lee HS, Chen CH, Huang GT, Lee PH, Sheu JC.
    J Gastroenterol Hepatol; 2005 Apr 10; 20(4):536-46. PubMed ID: 15836701
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P, Telzerow P, Moksness J, Breslow NE.
    Med Pediatr Oncol; 1996 Nov 10; 27(5):429-33. PubMed ID: 8926924
    [Abstract] [Full Text] [Related]

  • 8. Loss of heterozygosity at 7p in Wilms' tumour development.
    Powlesland RM, Charles AK, Malik KT, Reynolds PA, Pires S, Boavida M, Brown KW.
    Br J Cancer; 2000 Jan 10; 82(2):323-9. PubMed ID: 10646884
    [Abstract] [Full Text] [Related]

  • 9. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E, Li CM, Yamashiro DJ, Kandel J, Thaker H, Murty VV, Tycko B.
    Mol Cancer Res; 2005 Sep 10; 3(9):493-502. PubMed ID: 16179496
    [Abstract] [Full Text] [Related]

  • 10. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
    Schulz S, Becker KF, Braungart E, Reichmuth C, Klamt B, Becker I, Atkinson M, Gessler M, Höfler H.
    J Pathol; 2000 Jun 10; 191(2):162-9. PubMed ID: 10861576
    [Abstract] [Full Text] [Related]

  • 11. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.
    Grundy RG, Pritchard J, Scambler P, Cowell JK.
    Oncogene; 1998 Jul 23; 17(3):395-400. PubMed ID: 9690521
    [Abstract] [Full Text] [Related]

  • 12. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD, Freemerman AJ, Langdon S, Bentley R, Goyeau D, Grundy PE, Skinner MA.
    J Pediatr Surg; 2005 Feb 23; 40(2):341-8. PubMed ID: 15750927
    [Abstract] [Full Text] [Related]

  • 13. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK, Brown KW, Berry PJ.
    Am J Pathol; 1998 Sep 23; 153(3):991-1000. PubMed ID: 9736048
    [Abstract] [Full Text] [Related]

  • 14. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
    Huff V, Reeve AE, Leppert M, Strong LC, Douglass EC, Geiser CF, Li FP, Meadows A, Callen DF, Lenoir G.
    Cancer Res; 1992 Nov 01; 52(21):6117-20. PubMed ID: 1356625
    [Abstract] [Full Text] [Related]

  • 15. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors.
    Ruteshouser EC, Hendrickson BW, Colella S, Krahe R, Pinto L, Huff V.
    Genes Chromosomes Cancer; 2005 Jun 01; 43(2):172-80. PubMed ID: 15761866
    [Abstract] [Full Text] [Related]

  • 16. Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.
    Guertl B, Ratschek M, Harms D, Jaenig U, Leuschner I, Poremba C, Hoefler G.
    Hum Pathol; 2003 Mar 01; 34(3):278-81. PubMed ID: 12673563
    [Abstract] [Full Text] [Related]

  • 17. Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.
    Grundy RG, Pritchard J, Scambler P, Cowell JK.
    Br J Cancer; 1998 Nov 01; 78(9):1181-7. PubMed ID: 9820177
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11.
    Mannens M, Devilee P, Bliek J, Mandjes I, de Kraker J, Heyting C, Slater RM, Westerveld A.
    Cancer Res; 1990 Jun 01; 50(11):3279-83. PubMed ID: 2159377
    [Abstract] [Full Text] [Related]

  • 19. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM, Callen DF, Seshadri R, Goldup S, Mccallum B, Crawford J, Powell JA, Settasatian C, van Beerendonk H, Moerland EW, Smit VT, Harris WH, Millis R, Morgan NV, Barnes D, Mathew CG, Cornelisse CJ.
    Cancer Res; 2001 Feb 01; 61(3):1171-7. PubMed ID: 11221848
    [Abstract] [Full Text] [Related]

  • 20. Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis.
    Wittmann S, Zirn B, Alkassar M, Ambros P, Graf N, Gessler M.
    Genes Chromosomes Cancer; 2007 Feb 01; 46(2):163-70. PubMed ID: 17099873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.